Stockreport

RION Launches Rion Vet to Transform Animal Health with First-in-Class Exosome Biologics; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment [Yahoo! Finance]

Zoetis Inc. Class A  (ZTS) 
Last zoetis inc. class a earnings: 2/13 07:00 am Check Earnings Report
US:NYSE Investor Relations: investor.zoetis.com
PDF exosome-based therapeutics, today announced the formation of Rion Vet, a veterinary biotechnology company advancing platelet-derived exosome-based biologics to address m [Read more]